Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-25
DOI
10.1038/srep22251
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- Resveratrol increases CD68+Kupffer cells colocalized with adipose differentiation-related protein and ameliorates high-fat-diet-induced fatty liver in mice
- (2015) Kahoko Nishikawa et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- (2014) Forouzan Faghihzadeh et al. NUTRITION RESEARCH
- Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation
- (2013) João Marcus Oliveira Andrade et al. NUTRITION
- Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice
- (2012) Su-Jung Cho et al. BRITISH JOURNAL OF NUTRITION
- Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling
- (2012) Kento Imajo et al. Cell Metabolism
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
- (2012) Nathan L. Price et al. Cell Metabolism
- Metabolic Engineering of Yeast and Plants for the Production of the Biologically Active Hydroxystilbene, Resveratrol
- (2012) Philippe Jeandet et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The Efficacy of Licorice Root Extract in Decreasing Transaminase Activities in Non-alcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
- (2012) Ali Akbar Hajiaghamohammadi et al. PHYTOTHERAPY RESEARCH
- Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
- (2010) V. A. Brown et al. CANCER RESEARCH
- Elevated endotoxin levels in non-alcoholic fatty liver disease
- (2010) Alison L Harte et al. Journal of Inflammation-London
- Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase
- (2008) Jing SHANG et al. ACTA PHARMACOLOGICA SINICA
- Resveratrol alleviates alcoholic fatty liver in mice
- (2008) Joanne M. Ajmo et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Resveratrol inhibits nonalcoholic fatty liver disease in rats
- (2008) Luis Bujanda et al. BMC GASTROENTEROLOGY
- Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet
- (2008) Jiyun Ahn et al. JOURNAL OF HEPATOLOGY
- Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice
- (2008) Roberto Roncon-Albuquerque et al. LIFE SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started